Mentice AB (publ) (STO:MNTC)

Market Cap	280.69M
Revenue (ttm)	263.95M
Net Income (ttm)	-56.10M
Shares Out	28.13M
EPS (ttm)	-2.19
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,600
Average Volume	18,114
Open	9.82
Previous Close	9.80
Day's Range	9.82 - 9.98
52-Week Range	8.50 - 31.50
Beta	0.56
RSI	39.29
Earnings Date	Nov 6, 2025

About Mentice AB

Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedural learning models; patient simulator accessories and extensions for endovascular therapies; and Angiosuite integrations, such as the VIST virtual patie...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 131
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MNTC

Financial Performance

In 2024, Mentice AB's revenue was 291.81 million, an increase of 6.07% compared to the previous year's 275.12 million. Losses were -18.42 million, 553.9% more than in 2023.